IPAMORELIN 5mg

for: Growth Hormone Release Stimulant; Supports Muscle; Enhances Recovery.

Ipamorelin (5mg) is a specialized research pentapeptide utilized primarily to investigate the selective stimulation of growth hormone secretion and its impact on physiological recovery. As a potent agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a), it is distinguished by its high degree of selectivity, promoting growth hormone release without significantly elevating prolactin, cortisol, or ACTH. Dragon Pharma provides Ipamorelin 5mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of neuroendocrinology and metabolic signaling, few compounds offer as much precision as Ipamorelin. Known scientifically as a second-generation growth hormone secretagogue (GHS), this pentapeptide has become a fundamental tool for investigators exploring the pituitary gland's secretory capacity. Dragon Pharma provides Ipamorelin 5mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex biological models.

As scientific inquiry into metabolic disorders, sarcopenia, and tissue repair expands, the need for reliable, selective GHS agonists like Ipamorelin has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Ipamorelin 5mg.

Molecular Characteristics and Chemical Profile

• Chemical Identity: Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
• Molecular Formula: C38H49N9O5
• Molecular Weight: 711.85 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

Source: PubChem

The structural integrity of Ipamorelin is what allows it to bind specifically to the GHS-R1a receptor. Unlike earlier growth hormone secretagogues (such as GHRP-2 or GHRP-6), Ipamorelin is engineered to lack the terminal amino acid sequences that typically trigger secondary hormonal responses, making it one of the most selective peptides in its class.

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Growth Hormone Dynamics: Mapping pulsatile secretion patterns and pituitary somatotroph response.
• Gastric Motility: Investigating the "ghrelin-mimetic" effects on accelerated gastric emptying.
• Bone Mineralization: Studying the modulation of osteoblast activity and bone density in skeletal models.
• Muscle Homeostasis: Assessing nitrogen retention and protein synthesis in muscle-wasting research.
• Anti-Inflammatory Signaling: Evaluating the modulation of the systemic inflammatory response in preclinical models.

Pathway and Mechanistic Context

The core value of Ipamorelin 5mg in a laboratory setting is its ability to manipulate the growth hormone axis without inducing the "hunger spikes" or cortisol elevations associated with other analogs. In a natural physiological state, growth hormone release is a delicate balance of GHRH and Somatostatin. Ipamorelin bypasses this requirement by mimicking the action of Ghrelin at the receptor level.

The GHS-R1a Signaling Axis

Upon activation by Ipamorelin, the GHS-R1a receptor initiates a phospholipase C (PLC) signaling cascade. This results in the mobilization of intracellular calcium, leading to the exocytosis of growth hormone from the pituitary somatotrophs.

Key Mechanistic Shifts:

• Hormonal Selectivity: Ipamorelin activation leads to a "clean" GH release, facilitating studies where secondary stress hormone interference must be minimized.
• Pulsatile Mimicry: It maintains the natural pulsatile rhythm of GH secretion, which is critical for investigating long-term metabolic adaptations.
• IGF-1 Modulation: Activation leads to a downstream increase in Insulin-like Growth Factor 1 (IGF-1), a master regulator of cellular growth and repair.

Primary Research Applications

1. Sarcopenia and Lean Mass Research

Ipamorelin is heavily utilized in studies involving age-related muscle loss and frailty. Because it stimulates protein synthesis independently of androgenic pathways, it provides a unique framework for investigating how to restore lean tissue in catabolic research models.

2. Postoperative Recovery and Gastric Motility

Known in research circles as a potent prokinetic agent, Ipamorelin is used to observe how tissues adapt to perceived digestive stress. Investigators study its role in reversing postoperative ileus and normalizing gastric kinetics in animal models.

3. Bone Density and Osteogenesis

In skeletal research, Ipamorelin is studied for its ability to promote bone mineral density. Research models focusing on osteoporosis and fracture healing examine how Ipamorelin increases the rate of mineral accretion and bone strengthening.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Ipamorelin 5mg is produced under strict laboratory conditions to ensure that the compound remains stable and bioactive.

• Lyophilization for Stability: The compound is supplied in a lyophilized (freeze-dried) form. This process removes moisture while preserving the molecular sequence, ensuring it remains resistant to temperature fluctuations during transit.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the intended profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.

Author:

All information was searched/edited by Dr. S. Edwin, and Dr. E. Croft who holds a doctorate from Case Western Reserve University School of Medicine